This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Capellari, S. Articles by Petersen, R. B. Search for Related Content PubMed PubMed Citation Articles by Capellari, S. Articles by Petersen, R. B.

(American Journal of Pathology. 2000;157:613-622.)
© 2000 American Society for Investigative Pathology

Regular Articles

Effect of the E200K Mutation on Prion Protein Metabolism

Comparative Study of a Cell Model and Human Brain

From the Division of Neuropathology, Department of Pathology, Institute of Pathology, Case Western Reserve University, Cleveland, Ohio

The hallmark of prion diseases is the cerebral accumulation of a conformationally altered isoform (PrP^Sc) of a normal cellular protein, the prion protein (PrP^C). In the inherited form, mutations in the prion protein gene are thought to cause the disease by altering the metabolism of the mutant PrP (PrP^M) engendering its conversion into PrP^Sc. We used a cell model to study biosynthesis and processing of PrP^M carrying the glutamic acid to lysine substitution at residue 200 (E200K), which is linked to the most common inherited human prion disease. PrP^M contained an aberrant glycan at residue 197 and generated an increased quantity of truncated fragments. In addition, PrP^M showed impaired transport of the unglycosylated isoform to the cell surface. Similar changes were found in the PrP isolated from brains of patients affected by the E200K variant of Creutzfeldt-Jakob disease. Although the cellular PrP^M displayed some characteristics of PrP^Sc, the PrP^Sc found in the E200K brains was quantitatively and qualitatively different. We propose that the E200K mutation cause the same metabolic changes of PrP^M in the cell model and in the brain. However, in the brain, PrP^M undergoes additional modifications, by an age-dependent mechanism that leads to the formation of PrP^Sc and the development of the disease.

This article has been cited by other articles:

				R. B. Life, E.-G. Lee, S. W. Eastman, and M. L. Linial Mutations in the Amino Terminus of Foamy Virus Gag Disrupt Morphology and Infectivity but Do Not Target Assembly J. Virol., July 1, 2008; 82(13): 6109 - 6119. [Abstract] [Full Text] [PDF]

				L. Fioriti, S. Dossena, L. R. Stewart, R. S. Stewart, D. A. Harris, G. Forloni, and R. Chiesa Cytosolic Prion Protein (PrP) Is Not Toxic in N2a Cells and Primary Neurons Expressing Pathogenic PrP Mutations J. Biol. Chem., March 25, 2005; 280(12): 11320 - 11328. [Abstract] [Full Text] [PDF]

				Y. Kikuchi, T. Kakeya, A. Sakai, K. Takatori, N. Nakamura, H. Matsuda, T. Yamazaki, K.-i. Tanamoto, and J.-i. Sawada Propagation of a protease-resistant form of prion protein in long-term cultured human glioblastoma cell line T98G J. Gen. Virol., November 1, 2004; 85(11): 3449 - 3457. [Abstract] [Full Text] [PDF]

				G. Zanusso, A. Farinazzo, F. Prelli, M. Fiorini, M. Gelati, S. Ferrari, P. G. Righetti, N. Rizzuto, B. Frangione, and S. Monaco Identification of Distinct N-terminal Truncated Forms of Prion Protein in Different Creutzfeldt-Jakob Disease Subtypes J. Biol. Chem., September 10, 2004; 279(37): 38936 - 38942. [Abstract] [Full Text] [PDF]

				V. A. Lawson, S. A. Priola, K. Meade-White, M. Lawson, and B. Chesebro Flexible N-terminal Region of Prion Protein Influences Conformation of Protease-resistant Prion Protein Isoforms Associated with Cross-species Scrapie Infection in Vivo and in Vitro J. Biol. Chem., April 2, 2004; 279(14): 13689 - 13695. [Abstract] [Full Text] [PDF]

				K. Satoh, T. Muramoto, T. Tanaka, N. Kitamoto, J. W. Ironside, K. Nagashima, M. Yamada, T. Sato, S. Mohri, and T. Kitamoto Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases J. Gen. Virol., October 1, 2003; 84(10): 2885 - 2893. [Abstract] [Full Text] [PDF]

				B. Drisaldi, R. S. Stewart, C. Adles, L. R. Stewart, E. Quaglio, E. Biasini, L. Fioriti, R. Chiesa, and D. A. Harris Mutant PrP Is Delayed in Its Exit from the Endoplasmic Reticulum, but Neither Wild-type nor Mutant PrP Undergoes Retrotranslocation Prior to Proteasomal Degradation J. Biol. Chem., June 6, 2003; 278(24): 21732 - 21743. [Abstract] [Full Text] [PDF]

				D. A Harris Trafficking, turnover and membrane topology of PrP: Protein function in prion disease Br. Med. Bull., June 1, 2003; 66(1): 71 - 85. [Abstract] [Full Text] [PDF]

				H. Lorenz, O. Windl, and H. A. Kretzschmar Cellular Phenotyping of Secretory and Nuclear Prion Proteins Associated with Inherited Prion Diseases J. Biol. Chem., March 1, 2002; 277(10): 8508 - 8516. [Abstract] [Full Text] [PDF]

				S. Gauczynski, S. Krasemann, W. Bodemer, and S. Weiss Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance J. Cell Sci., January 11, 2002; 115(21): 4025 - 4036. [Abstract] [Full Text] [PDF]

				L. Ivanova, S. Barmada, T. Kummer, and D. A. Harris Mutant Prion Proteins Are Partially Retained in the Endoplasmic Reticulum J. Biol. Chem., November 2, 2001; 276(45): 42409 - 42421. [Abstract] [Full Text] [PDF]

				V. A. Lawson, S. A. Priola, K. Wehrly, and B. Chesebro N-terminal Truncation of Prion Protein Affects Both Formation and Conformation of Abnormal Protease-resistant Prion Protein Generated in Vitro J. Biol. Chem., September 14, 2001; 276(38): 35265 - 35271. [Abstract] [Full Text] [PDF]